StockData
Ensysce Biosciences, Inc. logo

Ensysce Biosciences, Inc. (ENSC) stock

ENSCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.37−0.01 (-3.62%)

Close on Nov 18, 2026Market cap $7.20MP/E –Yield –

Ensysce Biosciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Ensysce Biosciences's market cap was $5.84M on Nov 11, 2026, against $5.63M a year earlier. Over the last 5 years it ranged from $1.70M to $27.36B, with a median of $4.21M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$5.84M+99.7%
2025Dec 31, 2025$2.93M-61.1%
2024Dec 31, 2024$7.53M+148.0%
2023Dec 29, 2023$3.04M-84.7%
2022Dec 30, 2022$19.87M-99.9%
2021Dec 31, 2021$27.36B-34.9%
2020Dec 31, 2020$42.01B+21.6%
2019Dec 31, 2019$34.55B+8.1%
2018Dec 31, 2018$31.95B–

More Ensysce Biosciences figures

See a number that looks wrong?